KNTPF
Price
$0.33
Change
+$0.15 (+83.33%)
Updated
Aug 13 closing price
Capitalization
131.82M
UNCY
Price
$4.70
Change
+$0.07 (+1.51%)
Updated
Aug 15 closing price
Capitalization
60.01M
Interact to see
Advertisement

KNTPF vs UNCY

Header iconKNTPF vs UNCY Comparison
Open Charts KNTPF vs UNCYBanner chart's image
KINTOR PHARMACEUTICAL
Price$0.33
Change+$0.15 (+83.33%)
Volume$170
Capitalization131.82M
Unicycive Therapeutics
Price$4.70
Change+$0.07 (+1.51%)
Volume$564.51K
Capitalization60.01M
KNTPF vs UNCY Comparison Chart in %
Loading...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KNTPF vs. UNCY commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNTPF is a Buy and UNCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (KNTPF: $0.33 vs. UNCY: $4.70)
Brand notoriety: KNTPF and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNTPF: 24% vs. UNCY: 85%
Market capitalization -- KNTPF: $131.82M vs. UNCY: $60.01M
KNTPF [@Biotechnology] is valued at $131.82M. UNCY’s [@Biotechnology] market capitalization is $60.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNTPF’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • KNTPF’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, both KNTPF and UNCY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNTPF’s TA Score shows that 1 TA indicator(s) are bullish while UNCY’s TA Score has 3 bullish TA indicator(s).

  • KNTPF’s TA Score: 1 bullish, 2 bearish.
  • UNCY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, KNTPF is a better buy in the short-term than UNCY.

Price Growth

KNTPF (@Biotechnology) experienced а +85.68% price change this week, while UNCY (@Biotechnology) price change was +14.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNTPF($132M) has a higher market cap than UNCY($60M). KNTPF YTD gains are higher at: 105.875 vs. UNCY (-40.821).
KNTPFUNCYKNTPF / UNCY
Capitalization132M60M220%
EBITDAN/A-14.85M-
Gain YTD105.875-40.821-259%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A26.1M-
Total DebtN/A694K-
TECHNICAL ANALYSIS
Technical Analysis
KNTPFUNCY
RSI
ODDS (%)
Bearish Trend 3 days ago
63%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
32%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
26%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HBCYF13.120.26
+2.04%
HSBC Holdings Plc
SEAC5.00N/A
N/A
SeaChange International, Inc.
DNACF17.50N/A
N/A
Dena Co., Ltd.
SHPMF1.53N/A
N/A
Shanghai Pharmaceuticals Holdings Co., Ltd.
MFGCF1.21N/A
N/A
Mayfair Gold Corp.

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and MLEC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and MLEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
MLEC - KNTPF
27%
Poorly correlated
+0.67%
KNSA - KNTPF
20%
Poorly correlated
+0.30%
UNCY - KNTPF
20%
Poorly correlated
+1.51%
RLFTY - KNTPF
20%
Poorly correlated
N/A
BCTX - KNTPF
9%
Poorly correlated
+0.14%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with CDTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+1.51%
CDTX - UNCY
51%
Loosely correlated
+2.62%
INDP - UNCY
51%
Loosely correlated
-8.84%
ICU - UNCY
46%
Loosely correlated
-8.65%
CERO - UNCY
37%
Loosely correlated
-1.36%
UTHR - UNCY
32%
Poorly correlated
+0.34%
More